Development, characterization and application of predictive-toxicology models.

The adoption of SAR techniques for risk assessment purposes requires that the predictive performance of models be characterized and optimized. The development of such methods with respect to CASE/MULTICASE are described. Moreover, the effects of size, informational content, ratio of actives/inactives in the model on predictivity must be determined. Characterized models can provide mechanistic insights: nature of toxicophore, reactivity, receptor binding. Comparison of toxicophores among SAR models allows a determination of mechanistic overlaps (e.g., mutagenicity, toxicity, inhibition of gap junctional intercellular communication vs. carcinogenicity). Methods have been developed to combine SAR submodels and thereby improve predictive performance. Now that predictive toxicology methods are gaining acceptance, the development of Good Laboratory Practices is a further priority, as is the development of graduate programs in Computational Toxicology to adequately train the needed professional.

[1]  H. Rosenkranz,et al.  Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing. , 1996, Environmental health perspectives.

[2]  G. Klopman.  Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .

[3]  H S Rosenkranz,et al.  The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. , 1985, Mutation research.

[4]  H S Rosenkranz,et al.  Aspects of microbiology in cancer research. , 1973, Annual review of microbiology.

[5]  H S Rosenkranz,et al.  Structure activity-based predictive toxicology: an efficient and economical method for generating non-congeneric data bases. , 1991, Mutagenesis.

[6]  H S Rosenkranz,et al.  Evidence that cell toxicity may contribute to the genotoxic response. , 1994, Regulatory toxicology and pharmacology : RTP.

[7]  H. Rosenkranz,et al.  Estimation of the optimal data base size for structure-activity analyses: the Salmonella mutagenicity data base. , 1996, Mutation research.

[8]  G. Klopman.  MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .

[9]  J Ashby,et al.  Genetic toxicity and potential carcinogenicity of taxol. , 1994, Carcinogenesis.

[10]  H S Rosenkranz,et al.  Structural Analysis of a Group of Phytoestrogens for the Presence of a 2-D Geometric Descriptor Associated with Non-genotoxic Carcinogens and Some Estrogens , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  H S Rosenkranz,et al.  Application of structural concepts to evaluate the potential carcinogenicity of natural products. , 1996, SAR and QSAR in environmental research.

[12]  Michael Balls,et al.  Report and Recommendations of the CAAT 1 /ERGATT 2 Workshop on the Validation of Toxicity Test Procedures 3 , 1990 .

[13]  H. Rosenkranz,et al.  Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. , 1996, Bioorganic & medicinal chemistry.

[14]  M. Pike,et al.  A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.

[15]  H S Rosenkranz,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE. , 1994, Mutation research.

[16]  H S Rosenkranz,et al.  Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens. , 1996, Mutagenesis.

[17]  Gilles Klopman,et al.  META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism , 1994, J. Chem. Inf. Comput. Sci..

[18]  H S Rosenkranz,et al.  Toxicity estimation by chemical substructure analysis: the TOX II program. , 1995, Toxicology letters.

[19]  Gilles Klopman,et al.  META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..

[20]  H. Rosenkranz,et al.  Structure-activity relationships (SARs) among mutagens and carcinogens: a review. , 1986, Environmental mutagenesis.

[21]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[22]  H. Rosenkranz,et al.  Development of Methods to Ascertain the Predictivity and Consistency of SAR Models: Application to the U.S. National Toxicology Program Rodent Carcinogenicity Bioassays , 1997 .

[23]  H S Rosenkranz,et al.  An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases. , 1993, Mutagenesis.

[24]  H S Rosenkranz,et al.  The potential of organ specific toxicity for predicting rodent carcinogenicity. , 1996, Mutation research.

[25]  H. Rosenkranz,et al.  Chemical structure and genotoxicity: studies of the SOS chromotest. , 1996, Mutation research.

[26]  B. Ames,et al.  The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. , 1993, Environmental health perspectives.

[27]  H S Rosenkranz,et al.  Revisiting the role of mutagenesis in the induction of lung cancers in rats by diesel emissions. , 1993, Mutation research.

[28]  H. Rosenkranz,et al.  Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms. , 1998, Mutation research.

[29]  W. W. Nichols,et al.  Short-term tests for carcinogens and mutagens. , 1979, Mutation research.

[30]  H S Rosenkranz,et al.  Identification of structural features and associated mechanisms of action for carcinogens in rats. , 1998, Mutation research.

[31]  H. Rosenkranz,et al.  Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals. , 1995, Mutation research.

[32]  H S Rosenkranz,et al.  Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants. , 1990, Mutation research.

[33]  J. Ashby,et al.  Detection of human carcinogens , 1991, Nature.

[34]  H S Rosenkranz,et al.  A dichotomy in the lipophilicity of natural estrogens, xenoestrogens, and phytoestrogens. , 1997, Environmental health perspectives.

[35]  Herbert S. Rosenkranz,et al.  Risk Assessment and Decision Making Using Test Results , 1989 .

[36]  Julia Pet-Edwards,et al.  Risk assessment and decision making using test results : the carcinogenicity prediction and battery selection approach , 1989 .

[37]  H S Rosenkranz,et al.  Structural requirements for the mutagenicity of environmental nitroarenes. , 1984, Mutation research.

[38]  H S Rosenkranz,et al.  Structure-activity and mechanistic relationships: the effect of chemical overlap on structural overlap in data bases of varying size and composition. , 1996, Mutation research.

[39]  H S Rosenkranz,et al.  Identification of 'genotoxic' and 'non-genotoxic' alerts for cancer in mice: the carcinogenic potency database. , 1998, Mutation research.

[40]  H S Rosenkranz,et al.  Structural evidence for a dichotomy in rodent carcinogenesis: involvement of genetic and cellular toxicity. , 1993, Mutation research.